tiprankstipranks
Advertisement
Advertisement
Solu Therapeutics Emphasizes Mast Cell–Targeted Preclinical Immunology R&D
PremiumPrivate CompaniesSolu Therapeutics Emphasizes Mast Cell–Targeted Preclinical Immunology R&D
16d ago
Focus on Immunology Leadership Underscores Solu Therapeutics’ Scientific Orientation
Premium
Private Companies
Focus on Immunology Leadership Underscores Solu Therapeutics’ Scientific Orientation
23d ago
Solu Therapeutics Highlights Immunology Thought Leadership During Women’s History Month
Premium
Private Companies
Solu Therapeutics Highlights Immunology Thought Leadership During Women’s History Month
24d ago
Solu Therapeutics Highlights Immunology Platform Targeting Autoimmune Disease
PremiumPrivate CompaniesSolu Therapeutics Highlights Immunology Platform Targeting Autoimmune Disease
1M ago
Solu Therapeutics Emphasizes Immunology Platform Targeting Autoimmune and Inflammatory Diseases
Premium
Private Companies
Solu Therapeutics Emphasizes Immunology Platform Targeting Autoimmune and Inflammatory Diseases
1M ago
Solu Therapeutics Highlights Strategic Focus on Rare Hematologic Cancers
Premium
Private Companies
Solu Therapeutics Highlights Strategic Focus on Rare Hematologic Cancers
1M ago
Solu Therapeutics Emphasizes Focus on Leukemia Amid Evolving Cancer Survival Trends
PremiumPrivate CompaniesSolu Therapeutics Emphasizes Focus on Leukemia Amid Evolving Cancer Survival Trends
2M ago
Solu Therapeutics Emphasizes Focus on Hematologic Cancers Amid Evolving Oncology Landscape
Premium
Private Companies
Solu Therapeutics Emphasizes Focus on Hematologic Cancers Amid Evolving Oncology Landscape
2M ago
Solu Therapeutics Emphasizes Focus on CMML and AML Amid Evolving Cancer Outcomes
Premium
Private Companies
Solu Therapeutics Emphasizes Focus on CMML and AML Amid Evolving Cancer Outcomes
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100